Citations

Showing 10 of 108162 citations.

Frequency and Symptomatology of Hiccups in Patients With Cancer: Using an On-Line Medical Community to Better Understand the Patient Experience
Ehret, Christopher , Young, Colleen , Ellefson, Christine J., Aase, Lee , Jatoi, Aminah , Aase, Lee A, Young, Colleen D

Mayo Clinic

American Journal of Hospice and Palliative Medicine® | April 2, 2021 | Volume: 39 | Issue: 2 | Pages: 147-151

10.1177/10499091211006923 | PMID 33792359 Get It

Background: Cancer patients are at risk for hiccups, but the incidence and impact on quality of life are unclear. Methods: A survey (modified from the Functional Living Index with the inclusion of qualitative elements) was developed and launched on an 80,000-member medical social media platform, Mayo Clinic Connect https://connect.mayoclinic.org/ . Results: Among 213 respondents, 34 (16%; 95% CI: 11, 22%) reported “yes” that they had experienced hiccups with cancer therapy. Of those patients who reported hiccups, only 12 (35%) were men, and most were older than 50 years of age. Over 25% noted that hiccups occurred frequently around the time of cancer therapy; 30% described that hiccups interfered with their leisure or recreational activities; and over 15% described hiccups interfered with their ability to enjoy a meal. A few patients seemed to express frustration with hiccups with comments such as, “Totally uncontrollable,” “It’s extremely pain[ful] with throat cancer,” and “Once I had them bad. Almost choked.” Conclusion: Hiccups occur in16% of patients who are receiving cancer therapy and, by our estimates and extrapolation, appear highly problematic in approximately 5%.
Distal Radius Fracture Treatment Outcomes in Patients With Ipsilateral Hemiplegia or Hemiparesis
Munaretto, Nicholas , Tagliero, Adam J. , Rhee, Peter C. , Tagliero, Adam , Patel, Raahil , Rhee, Peter C , Munaretto, Nicholas

Mayo Clinic

HAND | April 2, 2021 | Volume: 17 | Issue: 1_suppl | Pages: 19S-24S

10.1177/1558944721999733 | PMID 33789515 Get It

Background Little information exists to guide decision-making with regard to distal radius fractures in the setting of ipsilateral hemiparesis or hemiplegia. Methods Patients who sustained a distal radius fracture in the setting of ipsilateral hemiparesis or hemiplegia secondary to brain injury were evaluated. Investigated variables included perioperative pain, preinjury House functional classification score, length of immobilization, radiographic outcome measurements, and time to union. Results There were 15 patients with distal radius fractures with a mean age of 65.9 years. The mean clinical and radiographic follow-up was 2.8 and 2.9 years, respectively. Wrists were placed into the nonoperative group (NOG, n = 10) and operative group (OG, n = 5). Pain significantly decreased at final follow-up for both groups. Baseline House functional classification scores averaged 1.3 and 1.6 for the NOG and OG, respectively, and were maintained at final follow-up. Length of immobilization for the NOG was 46 days and OG was 37 days, P = .15. Radiographic outcomes at final follow-up in the NOG and OG, respectively, were a mean radial height of 9.3 versus. 11.6 mm, radial inclination of 18.3° versus 22.3°, 4.2° dorsal tilt versus 5.3° volar tilt, and tear drop angle of 45.6° versus 44.5°. There were no significant differences in these measurements. Time to radiographic union averaged 58 days for the NOG and 67 days for the OG, P = .42. There were no revision surgeries. Conclusions Based on this small case series, patients with distal radius fracture and ipsilateral hemiparesis or hemiplegia may have similar clinical, functional, and radiographic outcomes, regardless of nonoperative or operative treatment.
Association of Pharmacogenetics With Adverse Events of Fluorouracil/Capecitabine in Patients With Cancer
King, Daniel A. , Diasio, Robert B. , Saif, Muhammad Wasif , Saif, M Wasif , Diasio, Robert B

Mayo Clinic

JCO Oncology Practice | April 1, 2021 | Volume: 17 | Issue: 7 | Pages: 453-454

10.1200/op.20.01072 | PMID 33793308 Get It

Diagnosis and Management of Neuroendocrine Disorders of Survivors of Brain Tumors
Erickson, Dana , Donegan, Diane

Mayo Clinic

American Society of Clinical Oncology Educational Book | April 1, 2021 | Volume: No volume available | Issue: 41 | Pages: 47-55

10.1200/edbk_321059 | PMID 33793312 Get It

Advances in the treatment of brain tumors have led to an increase in the number of survivors of this disease. Consequently, the long-term complications associated with past and current treatments are becoming more apparent. Of relevance to patients who receive treatment of brain tumors are the potential neuroendocrine complications that develop either acutely or several years following treatment. Presentation may differ between adults and children (e.g., short stature or adult growth hormone deficiency) but in both settings can complicate treatment and impact quality of life. The risk for the development of these complications depends on the location of the tumor (proximity to the pituitary/hypothalamus) and/or the treatment delivered (chemotherapy/surgery/radiation). Given the potential overlap in symptoms attributable to the underlying brain tumor and neuroendocrine dysfunction, a high level of suspicion, appropriate investigation, and administration of treatment may reduce morbidity and mortality for patients with brain tumors experiencing neuroendocrine dysfunction.
Hypertension and Prohypertensive Antineoplastic Therapies in Cancer Patients
Dorst, Daan C.H. van , Dobbin, Stephen J.H. , Neves, Karla B , Herrmann, Joerg , Mathijssen, Ron H.J. , Lang, Ninian N. , Lang, Ninian N , Herrmann, Sandra M. , Versmissen, Jorie , Danser, A.H. Jan

Mayo Clinic

Circulation Research | April 1, 2021 | Volume: 128 | Issue: 7 | Pages: 1040-1061

10.1161/circresaha.121.318051 | PMID 33793337 Get It

The development of a wide range of novel antineoplastic therapies has improved the prognosis for patients with a wide range of malignancies, which has increased the number of cancer survivors substantially. Despite the oncological benefit, cancer survivors are exposed to short- and long-term adverse cardiovascular toxicities associated with anticancer therapies. Systemic hypertension, the most common comorbidity among cancer patients, is a major contributor to the increased risk for developing these adverse cardiovascular events. Cancer and hypertension have common risk factors, have overlapping pathophysiological mechanisms and hypertension may also be a risk factor for some tumor types. Many cancer therapies have prohypertensive effects. Although some of the mechanisms by which these antineoplastic agents lead to hypertension have been characterized, further preclinical and clinical studies are required to investigate the exact pathophysiology and the optimal management of hypertension associated with anticancer therapy. In this way, monitoring and management of hypertension before, during, and after cancer treatment can be improved to minimize cardiovascular risks. This is vital to optimize cardiovascular health in patients with cancer and survivors, and to ensure that advances in terms of cancer survivorship do not come at the expense of increased cardiovascular toxicities.
Association of Virtual Surgical Planning With External Incisions in Complex Maxillectomy Reconstruction
Moore, Eric J. , Price, Daniel L., Abel, Kathryn M. Van , Janus, J.R., Moore, Ethan , Martin, Eli, Morris, Johnathan M., Alexander, Amy E. , Janus, Jeffery R, Moore, Ethan T, Van Abel, Kathryn M , Price, Daniel L. , Martin, Eliot J., Morris, Johnathan M.

Mayo Clinic

JAMA Otolaryngology–Head & Neck Surgery | April 1, 2021 | Volume: 147 | Issue: 6 | Pages: 526

10.1001/jamaoto.2021.0251 | PMID 33792635 Get It

Guideline-Driven Management of Hypertension
Carey, Robert M. , Wright, Jackson T. , Taler, Sandra J. , Whelton, Paul K.

Mayo Clinic

Circulation Research | April 1, 2021 | Volume: 128 | Issue: 7 | Pages: 827-846

10.1161/circresaha.121.318083 | PMID 33793326 Get It

Several important findings bearing on the prevention, detection, and management of hypertension have been reported since publication of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline. This review summarizes and places in context the results of relevant observational studies, randomized clinical trials, and meta-analyses published between January 2018 and March 2021. Topics covered include blood pressure measurement, patient evaluation for secondary hypertension, cardiovascular disease risk assessment and blood pressure threshold for drug therapy, lifestyle and pharmacological management, treatment target blood pressure goal, management of hypertension in older adults, diabetes, chronic kidney disease, resistant hypertension, and optimization of care using patient, provider, and health system approaches. Presenting new information in each of these areas has the potential to increase hypertension awareness, treatment, and control which remain essential for the prevention of cardiovascular disease and mortality in the future.
Racial, ethnic and socioeconomic disparities in patients undergoing left atrial appendage closure
Sparrow, Robbie , Sanjoy, Shubrandu , Choi, Yun‐Hee , Elgendy, Islam Y. , Jneid, Hani , Villablanca, Pedro , Holmes, David R. , Sposato, Luciano A. , Mamas, Mamas A. , Sparrow, Robert T. , Sposato, Luciano A , Mamas, Mamas , Bagur, Rodrigo , Elgendy, Islam Y , Sanjoy, Shubrandu S , Pershad, Ashish , Alraies, M Chadi , Bagur, Rodrigo

Mayo Clinic

Heart | April 1, 2021 | Volume: 107 | Issue: 24 | Pages: 1946-1955

10.1136/heartjnl-2020-318650 | PMID 33795381 Get It

Objective This manuscript aims to explore the impact of race/ethnicity and socioeconomic status on in-hospital complication rates after left atrial appendage closure (LAAC). Methods The US National Inpatient Sample was used to identify hospitalisations for LAAC between 1 October 2015 to 31 December 2018. These patients were stratified by race/ethnicity and quartiles of median neighbourhood income. The primary outcome was the occurrence of in-hospital major adverse events, defined as a composite of postprocedural bleeding, cardiac and vascular complications, acute kidney injury and ischaemic stroke. Results Of 6478 unweighted hospitalisations for LAAC, 58% were male and patients of black, Hispanic and ‘other’ race/ethnicity each comprised approximately 5% of the cohort. Adjusted by the older Americans population, the estimated number of LAAC procedures was 69.2/100 000 for white individuals, as compared with 29.5/100 000 for blacks, 47.2/100 000 for Hispanics and 40.7/100 000 for individuals of ‘other’ race/ethnicity. Black patients were ~5 years younger but had a higher comorbidity burden. The primary outcome occurred in 5% of patients and differed significantly between racial/ethnic groups (p<0.001) but not across neighbourhood income quartiles (p=0.88). After multilevel modelling, the overall rate of in-hospital major adverse events was higher in black patients as compared with whites (OR: 1.60, 95% CI 1.22 to 2.10, p<0.001); however, the incidence of acute kidney injury was higher in Hispanics (OR: 2.19, 95% CI 1.52 to 3.17, p<0.001). No significant differences were found in adjusted overall in-hospital complication rates between income quartiles. Conclusion In this study assessing racial/ethnic disparities in patients undergoing LAAC, minorities are under-represented, specifically patients of black race/ethnicity. Compared with whites, black patients had higher comorbidity burden and higher rates of in-hospital complications. Lower socioeconomic status was not associated with complication rates.
Enhanced Recovery in Gynecologic Surgery
Kalogera, Eleftheria , Nelson, Gregg , Dowdy, Sean C. , Nelson, Gregg S

Mayo Clinic

Journal of Gynecologic Surgery | April 1, 2021 | Volume: 37 | Issue: 2 | Pages: 122-126

10.1089/gyn.2021.0007 Get It